Glycomimetics Inc
GLYC
Revenue
18.50k
▼-16.88k▼-47.70%
9 Months ChangeAssets
24.42M
▼-9.79M▼-28.61%
3 Months ChangeLiabilities
4.36M
▼-937.89k▼-17.72%
3 Months ChangeFree Cash Flow
-10.52M
▲1.09M▲9.41%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001104659-24-112054
2024-08-08
Form 10-Q
ID: 0001558370-24-011579
2024-07-30
Form 8-K
ID: 0001558370-24-010370
2024-06-26
Form 8-K
ID: 0001558370-24-009508
2024-06-13
Form 8-K
ID: 0001558370-24-009140
2024-06-04
Form 8-K
ID: 0001558370-24-008882
2024-05-09
Form 10-Q
ID: 0001558370-24-007632
2024-05-06
Form 8-K
ID: 0001558370-24-006793
2024-05-02
Form 8-K
ID: 0001558370-24-006459
2024-03-27
Form 8-K
ID: 0001558370-24-004015